ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 104 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $170,000 | -37.7% | 20,953 | +29.6% | 0.07% | -49.3% |
| Q1 2022 | $273,000 | +23.0% | 16,165 | +56.6% | 0.14% | -35.5% |
| Q4 2021 | $222,000 | -70.5% | 10,324 | +1.3% | 0.22% | -55.5% |
| Q3 2021 | $753,000 | -17.4% | 10,190 | -38.9% | 0.49% | +24.2% |
| Q2 2021 | $912,000 | – | 16,684 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $109,318,155 | 33.89% |
| Vivo Capital, LLC | 4,220,048 | $47,560 | 5.48% |
| Logos Global Management LP | 2,349,600 | $26,479,992 | 3.10% |
| Samsara BioCapital, LLC | 262,786 | $2,961,598 | 0.64% |
| Orbimed Advisors | 2,871,000 | $32,356,170 | 0.62% |
| Pier Capital, LLC | 271,848 | $3,063,727 | 0.50% |
| Cormorant Asset Management, LP | 612,079 | $6,898 | 0.46% |
| Nan Fung Group Holdings Ltd | 41,950 | $472,777 | 0.33% |
| Artal Group S.A. | 500,000 | $5,635 | 0.32% |
| Redmile Group, LLC | 607,470 | $6,846,187 | 0.28% |